Replacement of Aging AgilePulse IM Systems to Support In Vivo Electroporation and Research Continuity

Closed Special Notice Posted

Solicitation number
PCA-NIAID-04170
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Cancer Institute issued a Notice of Intent to Sole Source on September 23, 2026, for replacement of two Harvard Apparatus AgilePulse IM electroporation systems with associated needle arrays, handles, installation and training services, and Silver Service Plans to support in vivo gene delivery research at the NIAID Vaccine Research Center. This procurement intends to bypass full-and-open competition under 41 U.S.C. § 3204(b)(2), citing sole-source justification that only one source is available; however, the Government will consider capability statements from other vendors to determine whether competitive procurement is warranted. The replacement systems will improve operational reliability, reduce downtime, and maintain consistency with established research protocols to ensure continuity of ongoing studies. Interested parties may submit capability statements via email to Veenu Varma at Veenu.varma@nih.gov by 12:00 pm Eastern Daylight Time on Wednesday, September 24, 2026, referencing "PCA-NIAID-04170." Late submissions will be handled in accordance with FAR 52.212-1(f). The Government reserves discretion to proceed with sole-source negotiation or convert to competitive procurement based on responses received.

Notice text

Title: Replacement of Aging AgilePulse IM Systems to Support In Vivo Electroporation and Research Continuity

This is a Notice of Intent to Sole Source (NOI), not a request for proposal. The National Cancer Institute intends to negotiate on an other-than-full-and-open competition basis with Harvard BioScience Inc. Purchase of two (2) Harvard Apparatus AgilePulse IM Systems with associated needle arrays, handles, installation/training services, and Silver Service Plans to replace aging electroporation systems supporting in vivo gene delivery research within the NIAID Vaccine Research Center. The replacement systems will improve operational reliability, reduce downtime, maintain consistency with established research protocols, and ensure continuity of ongoing research studies.

While this pre-solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement.   Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement by referencing “PCA-NIAID-04170”

The statutory authority for this sole source requirement is 41 U.S.C. 3204(b)(2) as implemented by FAR Overhaul 12.102(a) only one source is available. THIS IS NOT A REQUEST FOR PROPOSAL.

All responsible sources that could provide comparable products may submit a capability statement via email to Veenu Varma at:

Veenu.varma@nih.gov by 12:00 pm EASTERN Daylight Time, Wednesday, September 24, 2026.

Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Veenu Varma at veenu.varma@nih.gov.

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Annual Preventative Maintenance and Service Support for Seven (7) Miltenyi CliniMACS Prodigy Instruments Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors